The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Improvements in life expectancy among childhood cancer survivors: Uneven gains and remaining challenges.
 
Jennifer M Yeh
No Relationships to Disclose
 
Zachary J. Ward
No Relationships to Disclose
 
Kayla Stratton
No Relationships to Disclose
 
Gregory T. Armstrong
No Relationships to Disclose
 
Eric Jessen Chow
Research Funding - Abbott
 
Melissa M. Hudson
Consulting or Advisory Role - Oncology Research Information Exchange Network; Princess Máxima Center
 
Lindsay M. Morton
No Relationships to Disclose
 
Kevin C. Oeffinger
No Relationships to Disclose
 
Lisa Diller
Stock and Other Ownership Interests - Amgen (I); Apellis Pharmaceuticals (I); AstraZeneca (I); Baxter (I); crispr therapeutics (I); Intellia Therapeutics (I); LabCorp (I); Novartis (I); Novo Nordisk (I); Roche (I)
Patents, Royalties, Other Intellectual Property - My husband holds a patent with Massachusetts General Hospital for a drug currently in clinical trials. The drug is an inhibitor of BMP-1 (Alk2) receptor and is being studied in anemia of myelodysplastic syndrome and high-hepcidin level-associated anemias. (I)
 
Wendy M. Leisenring
No Relationships to Disclose